16 April 2026

Axial spondyloarthritis Clinical research

Acupuncture gains modest in axSpA trial

16 April 2026

Biologics psoriatic arthritis

Dual biologic boost in psoriatic arthritis

16 April 2026

Clinical research Imaging

Shoulder MRI findings ubiquitous after 40

16 April 2026

Clinical research Gastroenterology

IBS shows measurable biological signals

16 April 2026

Rheumatology

St Vincent’s Rheumatology Sydney celebrates 50 years

2 April 2026

Clinical research Pharmaceuticals Polymyalgia Rheumatica

Secukinumab boosts remission in PMR

2 April 2026

Arthritis Pain Research

$100m arthritis research mission push

2 April 2026

Axial spondyloarthritis Biologics Clinical research

Bimekizumab safety holds up with longer-term data

2 April 2026

Clinical research Dermatomyositis

Brepocitinib shows promise in phase 3 dermatomyositis trial

19 March 2026

Clinical research Psoriatic Athritis

GLP-1 RAs linked to lower PsA risk

19 March 2026

Biologics Psoriatic Athritis

Bimekizumab and risankizumab go head-to-head

19 March 2026

Arthritis Paediatrics

Hidden arthritis crisis hurting Aussie kids

19 March 2026

FDA Psoriatic Athritis

New oral option for psoriatic arthritis wins FDA nod

5 March 2026

Medicare specialists Uncategorized

Specialists unveil national ethical billing framework

5 March 2026

Biologics Lupus

Real-world lupus study shows rapid response to anifrolumab

5 March 2026

ACR EULAR Rheumatoid Arthritis

Pred habit not forever in early RA